SC 13G: Sagimet Biosciences Inc.
Ticker: SGMT · Form: SC 13G · Filed: Feb 14, 2024 · CIK: 1400118
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Sagimet Biosciences Inc..
Risk Assessment
Risk Level: low
Filing Stats: 1,255 words · 5 min read · ~4 pages · Grade level 11.9 · Accepted 2024-02-14 06:20:19
Key Financial Figures
- $0.0001 — Name of Issuer) Series A Common Stock, $0.0001 par value per share (Title of Class of
Filing Documents
- tm246036d6_sc13g.htm (SC 13G) — 56KB
- 0001104659-24-022724.txt ( ) — 58KB
(A). NAME OF ISSUER
ITEM 1(A). NAME OF ISSUER Sagimet Biosciences Inc. (the “Issuer”)
(B). ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES
ITEM 1(B). ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES Sagimet Biosciences Inc. 155 Bovet Road, Suite 303 San Mateo, CA 94402
(A). NAME OF PERSONS FILING
ITEM 2(A). NAME OF PERSONS FILING This Schedule is filed by KPCB Pandemic and Bio Defense Fund, LLC, a Delaware limited liability company, and KPCB PBD Associates, LLC, a Delaware limited liability company. The foregoing entities are collectively referred to as the “Reporting Persons.”
(B). ADDRESS OF PRINCIPAL OFFICE
ITEM 2(B). ADDRESS OF PRINCIPAL OFFICE The address for each of the Reporting Persons is: c/o Kleiner Perkins Caufield & Byers, LLC 2750 Sand Hill Road Menlo Park, California 94025
(C). CITIZENSHIP
ITEM 2(C). CITIZENSHIP See Row 4 of cover page for each Reporting Person.
(D). TITLE OF CLASS OF SECURITIES
ITEM 2(D). TITLE OF CLASS OF SECURITIES Series A Common Stock, par value $0.0001 per share (“Common Stock”)
(E). CUSIP NUMBER
ITEM 2(E). CUSIP NUMBER 786700104
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check
ITEM 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: Not applicable.
OWNERSHIP
ITEM 4. OWNERSHIP The following information with respect to the ownership of the ordinary shares of the Issuer by the persons filing this Statement is provided as of December 31, 2023: (a) Amount beneficially owned : See Row 9 of cover page for each Reporting Person. (b) Percent of Class : See Row 11 of cover page for each Reporting Person. CUSIP # 786700104 Page 5 of 8 (c) Number of shares as to which such person has : (i) Sole power to vote or to direct the vote : See Row 5 of cover page for each Reporting Person. (ii) Shared power to vote or to direct the vote : See Row 6 of cover page for each Reporting Person. (iii) Sole power to dispose or to direct the disposition of : See Row 7 of cover page for each Reporting Person. (iv) Shared power to dispose or to direct the disposition of : See Row 8 of cover page for each Reporting Person.
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not applicable.
OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Under certain circumstances set forth in the limited liability company agreements of the Reporting Persons, the members of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the Issuer owned by each such entity of which they are a member. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable.
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable.
NOTICE OF DISSOLUTION OF GROUP
ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable.
CERTIFICATION
ITEM 10. CERTIFICATION Not applicable. CUSIP # 786700104 Page 6 of 8
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 14, 2024 KPCB PANDEMIC AND BIO DEFENSE FUND, LLC, a Delaware limited liability company By: KPCB PBD ASSOCIATES, LLC, a Delaware limited liability company, its managing member By: /s/ Susan Biglieri Susan Biglieri Chief Financial Officer KPCB PBD ASSOCIATES, LLC, a Delaware limited liability company By: /s/ Susan Biglieri Susan Biglieri Chief Financial Officer CUSIP # 786700104 Page 7 of 8 EXHIBIT INDEX Found on Sequentially Exhibit Numbered Page Exhibit A: Agreement of Joint Filing 8 CUSIP # 786700104 Page 8 of 8 exhibit A Agreement of Joint Filing The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the common stock of the Issuer shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G. Date: February 14, 2024 KPCB PANDEMIC AND BIO DEFENSE FUND, LLC, a Delaware limited liability company By: KPCB PBD ASSOCIATES, LLC, a Delaware limited liability company, its managing member By: /s/ Susan Biglieri Susan Biglieri Chief Financial Officer KPCB PBD ASSOCIATES, LLC, a Delaware limited liability company By: /s/ Susan Biglieri Susan Biglieri Chief Financial Officer